Correlation Between Europlasma and Cellectis

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Europlasma and Cellectis at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Europlasma and Cellectis into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Europlasma SA and Cellectis, you can compare the effects of market volatilities on Europlasma and Cellectis and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Europlasma with a short position of Cellectis. Check out your portfolio center. Please also check ongoing floating volatility patterns of Europlasma and Cellectis.

Diversification Opportunities for Europlasma and Cellectis

0.82
  Correlation Coefficient

Very poor diversification

The 3 months correlation between Europlasma and Cellectis is 0.82. Overlapping area represents the amount of risk that can be diversified away by holding Europlasma SA and Cellectis in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cellectis and Europlasma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Europlasma SA are associated (or correlated) with Cellectis. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cellectis has no effect on the direction of Europlasma i.e., Europlasma and Cellectis go up and down completely randomly.

Pair Corralation between Europlasma and Cellectis

Assuming the 90 days trading horizon Europlasma SA is expected to under-perform the Cellectis. In addition to that, Europlasma is 7.31 times more volatile than Cellectis. It trades about -0.02 of its total potential returns per unit of risk. Cellectis is currently generating about -0.02 per unit of volatility. If you would invest  255.00  in Cellectis on September 2, 2024 and sell it today you would lose (62.00) from holding Cellectis or give up 24.31% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy100.0%
ValuesDaily Returns

Europlasma SA  vs.  Cellectis

 Performance 
       Timeline  
Europlasma SA 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Europlasma SA has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively weak basic indicators, Europlasma reported solid returns over the last few months and may actually be approaching a breakup point.
Cellectis 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Cellectis has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, Cellectis is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors.

Europlasma and Cellectis Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Europlasma and Cellectis

The main advantage of trading using opposite Europlasma and Cellectis positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Europlasma position performs unexpectedly, Cellectis can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cellectis will offset losses from the drop in Cellectis' long position.
The idea behind Europlasma SA and Cellectis pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.

Other Complementary Tools

Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Money Managers
Screen money managers from public funds and ETFs managed around the world
Insider Screener
Find insiders across different sectors to evaluate their impact on performance